FindTrial
Sign In

A Study on How Individualized Homeopathy Helps Migraine in Teenage Girls, Using MIDAS Scale

A PROSPECTIVE STUDY ON THE EFFICACY OF INDIVIDUALIZED HOMEOPATHIC MEDICINES IN THE TREATMENT OF MIGRAINE IN ADOLESCENT FEMALES, USING THE MIDAS SCALE - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105265
Enrollment
35
Registered
2026-03-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G43- Migraine

Interventions

Intervention1: individualized homeopathic medicine: individualised Medicine will be administerd based on the study subject individualisation suffering from migraine orally for the duration of once in

Sponsors

Dr Anusha Kammar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects who are already diagnosed with migraine will be included Only subjects who agree to participate will be included Subjects aged 10 to 19 years can take part regardless of their economic background Only subjects with a MIDAS score above 11 will be included. Subjects must agree to take only homeopathic treatment and attend monthly follow-ups for 6 months.

Exclusion criteria

Exclusion criteria: Subjects with known neurological disorders and other pathological or systemic disorders will not be included Subjects with a history of head injury will not be included Subjects who are undergoing other conventional treatment will not be included Subjects who are on hormone replacement therapy for PCOD and amenorrhea will not be included Subjects who are on prophylactic medication and supplements will not be included Subjects with complications of migraine according to ICHD such as status migrainosus persistent aura without infarction migrainous infarction and migraine aura triggered seizure will not be included

Design outcomes

Primary

MeasureTime frame
Improved Subjects having MIDAS Score less than or equal to 30 percent from the baseline score will be considered as improved Not Improved Subject having no significant improvement more than or equal to 30 percent baseline MIDAS score Subjects who are having the same score as before are considered to be not improvedTimepoint: once in 15 days for 2 months and later ONCE IN A MONTH for 4 months study duration is for 18 months—

Secondary

MeasureTime frame
not applicableTimepoint: not applicable—

Countries

India

Contacts

Public ContactDR JAIRAJ M PATIL

BHARATESH HOMEOPATHIC COLLEGE AND HOSPITAL

drjairajmpatilmd@gmail.com9916864400

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026